tiprankstipranks
Trending News
More News >
Emmaus Life Sciences Inc (EMMA)
OTHER OTC:EMMA
US Market

Emmaus Life Sciences (EMMA) Financial Statements

Compare
88 Followers

Emmaus Life Sciences Financial Overview

Emmaus Life Sciences's market cap is currently $894.12K. The company's EPS TTM is $-0.032; its P/E ratio is -0.12; Emmaus Life Sciences is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Jun 24Dec 22Mar 22Dec 20
Income Statement
Total Revenue$ 16.65M$ 29.60M$ 18.39M$ 20.61M$ 23.17M
Gross Profit$ 15.45M$ 28.25M$ 15.80M$ 17.30M$ 20.92M
Operating Income$ -1.89M$ 3.54M$ -6.59M$ -6.13M$ -32.00K
EBITDA$ -910.00K$ 3.62M$ -5.50M$ -12.76M$ 7.02M
Net Income$ -6.45M$ -3.73M$ -10.63M$ -15.95M$ 1.35M
Balance Sheet
Cash & Short-Term Investments$ 1.39M$ 2.55M$ 2.02M$ 2.28M$ 2.49M
Total Assets$ 23.60M$ 35.18M$ 48.23M$ 56.73M$ 59.27M
Total Debt$ 32.96M$ 32.65M$ 30.82M$ 29.91M$ 18.99M
Net Debt$ 31.57M$ 30.10M$ 28.80M$ 27.64M$ 16.50M
Total Liabilities$ 80.08M$ 82.94M$ 82.32M$ 78.18M$ 64.69M
Stockholders' Equity$ -56.48M$ -47.76M$ -34.09M$ -21.45M$ -5.42M
Cash Flow
Free Cash Flow$ -2.30M$ -1.52M$ -5.10M$ -1.33M$ -28.63M
Operating Cash Flow$ -2.29M$ -1.50M$ -5.07M$ -1.25M$ -2.45M
Investing Cash Flow$ 2.50M$ -432.00K$ -2.39M$ -6.38M$ 5.47M
Financing Cash Flow$ -1.35M$ 2.48M$ 7.23M$ 7.41M$ -2.31M
Currency in USD

Emmaus Life Sciences Earnings and Revenue History

Emmaus Life Sciences Debt to Assets

Emmaus Life Sciences Cash Flow

Emmaus Life Sciences Forecast EPS vs Actual EPS